MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma
Abstract Background Minichromosome maintenance complex component 6 (MCM6), as an important replication permission factor, is involved in the pathogenesis of various tumors. Here we studied the expression of MCM6 in neuroblastoma and its influence on tumor characteristics and prognosis. Methods Publi...
Main Authors: | Yaoyao Gu, Xiaoxiao Hu, Xiaowei Liu, Cheng Cheng, Kai Chen, Yeming Wu, Zhixiang Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08344-z |
Similar Items
-
MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment
by: Patrizia Garbati, et al.
Published: (2020-11-01) -
MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression
by: Zhikun Liu, et al.
Published: (2018-02-01) -
Prognostic significance of MCM 2 and Ki-67 in neuroblastic tumors in children
by: Magdalena Lewandowska, et al.
Published: (2015-12-01) -
Prp19 Is an Independent Prognostic Marker and Promotes Neuroblastoma Metastasis by Regulating the Hippo-YAP Signaling Pathway
by: Yuanxia Cai, et al.
Published: (2020-11-01) -
Desenvolvimento de material micro-mesoporoso do tipo MCM-22/MCM-41: sítese e caracterização.
by: FREIRE, Vitória de Andrade.
Published: (2016)